Document is current
Any future updates will be listed below
-
Authors
Selicean, Sonia-Emilia
Felli, Eric
Wang, Cong
Nulan, Yeldos
Lozano, Juan José
Guixé-Muntet, Sergi
Ștefănescu, Horia
Bosch, Jaime
Berzigotti, Annalisa
Gracia-Sancho, Jordi
-
Funding
Funding for this research was provided by:
European Association for the Study of the Liver
Swiss Government Excellence Scholarships
Stiftung für Leberkrankheiten
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_189252/1, 320030_189252/1, 320030_189252/1)
China Scholarship Council
Sara Borrell Fellowship from Instituto de Salud Carlos III
Swiss Foundation against Liver Cancer
Novartis (39-269)
Instituto de Salud Carlos III (FIS PI23/00945 and DTS22/00010)
AGAUR-Generalitat de Catalunya (2021 SGR 01322 & 2021 PROD 00036)
- License Information
-
More Information
Article History
Received: 14 March 2024
Accepted: 19 July 2024
First Online: 1 October 2024
Competing interests
: J.B. is a consultant for Astra-Zeneca, Boehringer-Ingelheim, Novo-Nordisk, and Resolution Therapeutics. A.B. is a consultant for Boehringer-Ingelheim.
